Literature DB >> 18082594

Paradigms for the three rs: DNA replication, recombination, and repair.

Philip C Hanawalt1.   

Abstract

The recent decade has engendered a convergence of the otherwise distinct fields of DNA replication, recombination, and repair, as we are learning how these essential transactions can operate in coordination to achieve genomic stability and to ensure cellular viability. In the next decade, we can anticipate a functional understanding of the roles of posttranslational protein modifications in the regulation and prioritizing of pathways for genomic maintenance. The fundamental knowledge gained should lead to more effective clinical intervention in human disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082594     DOI: 10.1016/j.molcel.2007.11.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  19 in total

1.  Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosis.

Authors:  Xiaobo Zhou; Karl Münger
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  DNA glycosylase activity and cell proliferation are key factors in modulating homologous recombination in vivo.

Authors:  Orsolya Kiraly; Guanyu Gong; Megan D Roytman; Yoshiyuki Yamada; Leona D Samson; Bevin P Engelward
Journal:  Carcinogenesis       Date:  2014-08-25       Impact factor: 4.944

3.  Emerging links between premature ageing and defective DNA repair.

Authors:  Philip C Hanawalt
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

4.  DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.

Authors:  Fanny Lemée; Valérie Bergoglio; Anne Fernandez-Vidal; Alice Machado-Silva; Marie-Jeanne Pillaire; Anne Bieth; Catherine Gentil; Lee Baker; Anne-Laure Martin; Claire Leduc; Elena Lam; Eddy Magdeleine; Thomas Filleron; Naïma Oumouhou; Bernd Kaina; Mineaki Seki; Fanny Grimal; Magali Lacroix-Triki; Alastair Thompson; Henri Roché; Jean-Christophe Bourdon; Richard D Wood; Jean-Sébastien Hoffmann; Christophe Cazaux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

5.  Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.

Authors:  Paola Neri; Li Ren; Kathy Gratton; Erin Stebner; Jordan Johnson; Alexander Klimowicz; Peter Duggan; Pierfrancesco Tassone; Adnan Mansoor; Douglas A Stewart; Sagar Lonial; Lawrence H Boise; Nizar J Bahlis
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

6.  Rad52/Rad59-dependent recombination as a means to rectify faulty Okazaki fragment processing.

Authors:  Miju Lee; Chul-Hwan Lee; Annie Albert Demin; Palinda Ruvan Munashingha; Tamir Amangyeld; Buki Kwon; Tim Formosa; Yeon-Soo Seo
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

7.  A novel ATM-dependent X-ray-inducible gene is essential for both plant meiosis and gametogenesis.

Authors:  Philip J Dean; Tanja Siwiec; Wanda M Waterworth; Peter Schlögelhofer; Susan J Armstrong; Christopher E West
Journal:  Plant J       Date:  2009-02-02       Impact factor: 6.417

8.  Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity.

Authors:  Fabricio G Sousa; Renata Matuo; Sai-Wen Tang; Vinodh N Rajapakse; Augustin Luna; Chris Sander; Sudhir Varma; Paul H G Simon; James H Doroshow; William C Reinhold; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2015-02-11

9.  Expression of XPG protein in human normal and tumor tissues.

Authors:  Miguel Aracil; Lisa M Dauffenbach; Marta Martínez Diez; Rana Richeh; Victoria Moneo; Juan Fernando Martínez Leal; Luis Francisco García Fernández; Christopher A Kerfoot; Carlos M Galmarini
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

10.  Unique and important consequences of RECQ1 deficiency in mammalian cells.

Authors:  Sudha Sharma; Robert M Brosh
Journal:  Cell Cycle       Date:  2008-01-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.